To obtain rapid remission of life-threatening severe haemolysis (Hb <60 g/L), restore effective oxygen supplies, and avoid the aggravation of organ dysfunction due to severe anaemia, a new strategy is expected, and WBE may be a promising therapeutic way by providing the dual benefits of removing harmful components and supplementing fresh healthy RBCs. This evidence concerns the gene GSTM1 and anemia (phenotype).